NEW YORK (GenomeWeb) – The National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium (CPTAC) is partnering with the University of Victoria Genome British Columbia Proteomics Centre to develop targeted proteomic assays.
Researchers led by Christoph Borchers, director of the Proteomics Centre, will upload some 2,000 multiple reaction monitoring mass spec assays to the CPTAC Assay Portal. Borchers and his colleagues will be the first non-CPTAC researchers to upload targeted mass spec assays to the portal.
The partnership is part of CPTAC's effort to more broadly distribute resources developed by the consortium and establish platforms benefitting the general research community. The consortium aims to make the Assay Portal a centralized repository that CPTAC and non-CPTAC researchers can use to upload and download targeted proteomic assays with rigorous standard operating procedures and guidelines.
"We are delighted to be working with the CPTAC on this important project," Borchers said in a statement. "Standardization of protein quantitation is essential if mass spectrometry-based proteomics is going to be used for clinical assays."